HPLC of acetyl-L-carnitine in human plasma by derivatization with p-bromophenacyl bromide

被引:5
|
作者
Park, KM
Lee, MK
Park, YH
Woo, JS
Kim, CK
机构
[1] Seoul Natl Univ, Coll Pharm, Natl Res Lab Bioact Delivery Syst, Seoul 151742, South Korea
[2] Hanmi Pharm Co Ltd, Cent Res Inst, Hwasung Gun 445910, Kyonggi Do, South Korea
关键词
D O I
10.1081/JLC-100103393
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A high performance liquid chromatographic method is developed for the determination of acetyl-L-carnitine (ALC), an endogenous carnitine derivative, in human plasma, e-Carnitine, which is the structural analogue of ALC, was used as an internal standard. The human plasma samples were treated with ninhydrin solution for the removal of amino acids and then extracted with methanol. After solid phase extraction on silica columns, samples were derivatized with p-bromophenacyl bromide in the presence of 18-crown-6. The derivative of ALC was quantified by high-performance liquid chromatography with UV detection at 260 nm. The retention time of ALC and e-carnitine was about 27.5 and 22.3 min, respectively. The limit of quantitation was 0.22 nmol/mL, based on signal to noise ratio of 3. The accuracy deviation of assay was less than 12.86%, and the intra-day and inter-day coefficients of variation (CV, %) were lower than 5.18 and 5.06%, respectively.
引用
收藏
页码:555 / 563
页数:9
相关论文
共 50 条
  • [41] Evaluation of the protective effect of L-carnitine and acetyl-L-carnitine on human spermatozoa during freezing and thawing
    Agarwal, A.
    Park, N. C.
    Said, T. M.
    Park, H. J.
    Lee, W.
    Seo, W. J.
    HUMAN REPRODUCTION, 2003, 18 : 143 - 143
  • [42] P-BROMOPHENACYL BROMIDE POTENTIATES HYDROGEN-PEROXIDE FORMATION IN HUMAN PLATELETS CHALLENGED BY THROMBIN AND INHIBITS AGGREGATION
    LEONCINI, G
    APRILE, B
    MARESCA, M
    BIOCHEMISTRY AND MOLECULAR BIOLOGY INTERNATIONAL, 1993, 29 (02): : 317 - 325
  • [43] Acetyl-L-carnitine and peripheral neuropathy - Summary and conclusions
    Sima, Anders A. F.
    CNS DRUGS, 2007, 21 : 45 - 46
  • [44] HPLC determination and pharmacokinetics of endogenous acetyl-L-carnitine (ALC) in human volunteers orally administered a single dose of ALC
    Kwon, OS
    Chung, YB
    ARCHIVES OF PHARMACAL RESEARCH, 2004, 27 (06) : 676 - 681
  • [45] Acetyl-l-Carnitine Treatment in Minimal Hepatic Encephalopathy
    Mariano Malaguarnera
    Maria Pia Gargante
    Erika Cristaldi
    Marco Vacante
    Corrado Risino
    Lisa Cammalleri
    Giovanni Pennisi
    Liborio Rampello
    Digestive Diseases and Sciences, 2008, 53 : 3018 - 3025
  • [46] ACTIVITY OF ACETYL-L-CARNITINE IN PRIMARY DEGENERATIVE DEMENTIA
    BERGAMASCO, P
    TARENZI, L
    LEOTTA, D
    SCARZELLA, L
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1986, 31 (1-4) : 154 - 154
  • [47] Role of acetyl-L-carnitine in the brain: revealed by Bioradiography
    Tanaka, M
    Nakamura, F
    Mizokawa, S
    Matsumura, A
    Matsumura, K
    Watanabe, Y
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 306 (04) : 1064 - 1069
  • [48] Study of Mechanisms for Acetyl-L-Carnitine Neuroprotective Action
    Cunha, L.
    Damiani, D.
    Alves, C.
    Metello, L. F.
    Summavielle, T.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S388 - S388
  • [49] Oral Acetyl-L-Carnitine Therapy and Insulin Resistance
    Ruggenenti, Piero
    van der Meer, Irene M.
    Remuzzi, Giuseppe
    HYPERTENSION, 2010, 55 (06) : E26 - E26
  • [50] Acetyl-l-carnitine improves aged brain function
    Kobayashi, Satoru
    Iwamoto, Machiko
    Kon, Kazuo
    Waki, Hatsue
    Ando, Susumu
    Tanaka, Yasukazu
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2010, 10 : S99 - S106